AlphaYouRC
Insider buying
Robert Charles Jahr bought Outlook Therapeutics, Inc. (OTLK) stock
Robert Charles Jahr, Chief Executive Officer of Outlook Therapeutics, Inc. (OTLK), bought 151,515 shares of OTLK stock, per an SEC Form 4 filed Aug 15, 2026.
The shares came through a private deal, not the open market.
The trade happened on Aug 14, 2026, 1 day before it was made public.
OTLK has moved -9.3% since the trade date, from $0.76 to $0.69 (Sep 21, 2026 close).
- Traded
- Aug 14, 2026
- Disclosed
- Aug 15, 2026
- Filing delay
- 1 day
- Price since
- -9.3%
- Role
- Chief Executive Officer
- Source
- SEC Form 4
More OTLK insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.